# Stomach Neoplasms trials: 505 new since Nov 2024

Updated November 9, 2026.

505 clinical studies in Stomach Neoplasms were first posted on ClinicalTrials.gov from November 13, 2024 to November 9, 2026; 102 have an industry sponsor and 398 are recruiting or about to. The newest, NCT07924189, was posted on November 9, 2026: Association of Psychological Distress With Clinical Outcomes in Patients With Digestive System Cancers (Xuanwu Hospital, Beijing).

## The full list

New Stomach Neoplasms clinical trials: 505 rows for $25.25, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 25 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/stomach-neoplasms

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 505
- Industry sponsored: 102
- Recruiting or not yet: 398
- Latest posted: November 9, 2026

## Newest trials

The newest 100 of 505, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07924189 | Association of Psychological Distress With Clinical Outcomes in Patients With Digestive System Cancers | Xuanwu Hospital, Beijing | Observational | Active not recruiting | Psychological Distress, Pancreatic Cancer, Colorectal Cancer, Gastric Cancer | 100 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924189) |
| November 6, 2026 | NCT07923396 | GK01 Cell Therapy in Gastric Cancer With Peritoneal Metastasis | Ruijin Hospital | Phase 1 | Not yet recruiting | Gastric Cancer (GC) | 10 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923396) |
| November 6, 2026 | NCT07923214 | A Phase I Study of CG-7321 Monotherapy or Combination Therapy in Advanced Solid Tumors | Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. | Phase 1 | Recruiting | Advanced Solid Tumors, Breast Cancer, Ovarian Cancer, Gastric Cancer, Other Solid Tumors | 30 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923214) |
| November 6, 2026 | NCT07920705 | Nutritional Intervention After Total Gastrectomy for Gastric Cancer | Hanoi Medical University | Not applicable | Completed | Gastric Cancer (GC) | 84 | Vietnam | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920705) |
| November 5, 2026 | NCT07920224 | Candonilimab Combined With Fruquintinib and Paclitaxel Albumin-Bound as Second-Line Treatment for Advanced Gastric or Gastro-esophageal... | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 | Recruiting | Stomach Neoplasms | 59 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920224) |
| November 5, 2026 | NCT07920068 | Epinephrine 1:100,000 Versus 1:500,000 During Gastric Endoscopic Submucosal Dissection | Unidade Local de Saúde do Alto Ave, EPE | Not applicable | Recruiting | Gastric Neoplasms, Gastric Dysplasia | 100 | Portugal | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920068) |
| November 3, 2026 | NCT07913165 | A Study of Trifluridine/Tipiracil (TAS-102) Combined With Nedaplatin for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma... | Tao Zhang | Phase 2 | Not yet recruiting | Gastric Cancer (GC) | 36 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913165) |
| November 3, 2026 | NCT07912606 | D2 Gastrectomy With or Without Para-Aortic Lymph Node Dissection After Chemoimmunotherapy for Gastric Cancer | The First Affiliated Hospital with Nanjing Medical University | Phase 2 | Not yet recruiting | Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | 32 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912606) |
| November 2, 2026 | NCT07911280 | A Phase II, Trial of Neoadjuvant Trastuzumab + Durvalumab + FLOT Targeted Immunochemotherapy | Samsung Medical Center | Phase 2 | Recruiting | Gastric Cancer | 20 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911280) |
| November 2, 2026 | NCT07911267 | Development and Utilization of an Integrated Clinical Genomic Database | Samsung Medical Center | Observational | Recruiting | Gastric Cancer, Colorectal Cancer, Lung Cancer (NSCLC), Liver Cancer, Pancreatic Cancer | 118,750 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911267) |
| October 29, 2026 | NCT07904442 | Application of Intraperitoneal Hyperthermic Chemotherapy in the Treatment of Gastric Cancer With Peritoneal Metastasis | Anhui Provincial Cancer Hospital | Phase 2 | Not yet recruiting | Gastric Cancer (Diagnosis) | 32 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904442) |
| October 29, 2026 | NCT07904260 | Effect of High-flow Nasal Cannula Oxygenation on the Incidence of Hypoxemia During Painless Gastrointestinal Endoscopy in Patients at High... | Diansan Su | Not applicable | Not yet recruiting | Hypoxemia, Gastric Cancer (Diagnosis), Esophageal Cancer, High-altitude Illness, Obstructive Sleep Apnea (OSA) | 430 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904260) |
| October 29, 2026 | NCT07903857 | SND002 Cell Injection in Participants With Advanced Malignant Solid Tumors | Guizhou Sinorda Pharmaceutical Co., Ltd. | Phase 1 | Not yet recruiting | Colorectal Neoplasms, Stomach Neoplasms, Solid Tumor Malignancies | 78 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903857) |
| October 29, 2026 | NCT07903415 | A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors. | Pfizer | Phase 1 | Recruiting | Pancreatic Ductal Adenocarcinoma, Esophageal Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC), Gastric Carcinoma... | 280 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903415) |
| October 29, 2026 | NCT07902648 | Serplulimab, DOS and Lenvatinib Combine With PIPAC in the Oligometastatic Peritoneal Metastasis of Gastric/Gastroesophageal Junction... | Fujian Cancer Hospital | Phase 2 | Not yet recruiting | Gastric/Gastroesophageal Junction Adenocarcinoma, Oligometastatic Peritoneal Metastasis | 42 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902648) |
| October 29, 2026 | NCT07902596 | Lymph Node Dissection After Neoadjuvant Therapy for Gastric and EGJ Adenocarcinoma | The First Affiliated Hospital with Nanjing Medical University | Observational | Not yet recruiting | Gastric Adenocarcinoma, Esophagogastric Junction Adenocarcinoma | 2,000 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902596) |
| October 28, 2026 | NCT07899775 | Lymph Node Metastasis Pattern After Neoadjuvant Chemoimmunotherapy in LAGC | Hainan General Hospital | Observational | Not yet recruiting | Stomach Neoplasms, Gastric Cancer (Diagnosis), Gastric Adenocarcinoma | 103 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899775) |
| October 27, 2026 | NCT07899697 | Feasibility Study of Middle Segmental Gastrectomy (MSG) for Gastric Cancer. | National Cancer Center, Korea | Not applicable | Active not recruiting | Gastric Cancer, Gastric Adenocarcinoma, Middle Segmental Gastrectomy (MSG), Function-preserving Surgery, Dumping... | 78 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899697) |
| October 27, 2026 | NCT07899632 | A Study of MDSY-1240, a STAT3 Degrader, for the Treatment of Hematologic Malignancies and Advanced Solid Tumors | Medsyn Biopharma, LLC | Phase 1/2 | Not yet recruiting | Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic, Ovarian Cancer... | 75 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899632) |
| October 27, 2026 | NCT07898293 | TEAS for Gastrectomy Recovery | The Affiliated Hospital of Qingdao University | Not applicable | Recruiting | Gastric Cancer (GC), Stomach Neoplasms | 104 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898293) |
| October 27, 2026 | NCT07897227 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SYS6062 in Patients With Advanced Solid Tumors. | CSPC Megalith Biopharmaceutical Co.,Ltd. | Phase 1/2 | Not yet recruiting | Advanced Solid Tumors, Gastric Cancer (GC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) | 260 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897227) |
| October 23, 2026 | NCT07892183 | SPADE Clinical Trial. | National Cancer Center, Korea | Not applicable | Recruiting | Early Gastric Cancer, Adenocarcinoma of the Stomach, Proximal Gastric Cancer, SPADE Operation, Reflux Esophagitis... | 159 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07892183) |
| October 20, 2026 | NCT07884669 | Biomarker Investigation for Early Gastric Cancer Detection | Centre Leon Berard | Not applicable | Not yet recruiting | Gastro Oesophageal Cancer | 100 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07884669) |
| October 20, 2026 | NCT07882212 | GRACE-DE: Prospective Multicenter Real-world Gastric Cancer Patients Starting AZ-developed and Approved Drugs in Germany (Umbrella Study) | AstraZeneca | Observational | Not yet recruiting | Gastric Cancer, Gastroesophageal Junction Cancer | 300 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07882212) |
| October 19, 2026 | NCT07881133 | Perioperative Biomarkers in Colorectal and Gastric Cancer Surgery | Bucharest Emergency Hospital | Not applicable | Recruiting | Colorectal (Colon or Rectal) Cancer, STOMACH NEOPLASM | 320 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881133) |
| October 19, 2026 | NCT07880106 | Multimodal Liquid-Biopsy Omics Biomarkers of Treatment Response in Breast Cancer | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Observational | Not yet recruiting | Lung Cancer Non-small Cell, Colorectal Cancer, Stomach Cancer, Hepatocellular Carcinoma, Breast Cancer | 2,000 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880106) |
| October 14, 2026 | NCT07874425 | Retlirafusp Alfa Combined With Zeprumetostat, Apatinib, and Chemotherapy as First-Line Treatment for Metastatic GC/GEJC | Fudan University | Phase 2 | Not yet recruiting | Gastric Cancer/Gastroesophageal Junction Adenocarcinoma | 55 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874425) |
| October 14, 2026 | NCT07873580 | European Implementation Study on Simultaneous Screening for Gastric and Colorectal Cancers | University of Latvia | Observational | Not yet recruiting | Helicobacter Pylori Infection, Colorectal Cancer, Gastric Cancer | 8,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07873580) |
| October 14, 2026 | NCT07872722 | Zolbetuximab, Durvalumab, and FLOT Combination Neoadjuvant Chemotherapy for CLDN18.2-Positive Gastric Cancer or Gastroesophageal Junction... | National Cancer Center, Japan | Phase 2 | Recruiting | CLDN18.2-Positive Gastric Cancer, CLDN18.2-Positive Gastroesophageal Junction Adenocarcinoma | 29 | Japan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07872722) |
| October 14, 2026 | NCT07872696 | Exploring the Efficacy of Ferrous Sulfate/Ferrous Succinate Combined With Serplulimab and SOX Regimen in Neoadjuvant Therapy for Gastric... | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 | Not yet recruiting | Gastric Neoplasms | 54 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07872696) |
| October 7, 2026 | NCT07863024 | Safety and Efficacy Study in Adults With Advanced Solid Tumors Receiving REGN13089-M404-M2980, an Antibody-drug Conjugate That Targets MET... | Regeneron Pharmaceuticals | Phase 1/2 | Not yet recruiting | Advanced Solid Tumors | 320 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07863024) |
| October 5, 2026 | NCT07859254 | Pathological Response to Perioperative FLOT in Gastric Adenocarcinoma | Fundación Santa Fe de Bogota | Observational | Not yet recruiting | Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Stomach Neoplasms | 90 | Colombia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07859254) |
| October 5, 2026 | NCT07858500 | Zolbetuximab and Other Cancer Treatments in People With Advanced Gastric or GEJ Cancer in Clinical Practice (RADIANCE) | Astellas Pharma Europe Ltd. | Observational | Not yet recruiting | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable... | 1,000 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07858500) |
| October 5, 2026 | NCT07857668 | LECS Combined With LSNNS for Early Gastric Cancer (LENS Trial) | Peking University People's Hospital | Observational | Recruiting | Early Gastric Cancer | 40 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07857668) |
| October 2, 2026 | NCT07856212 | Maintenance Therapy in Metastatic Gastric Cancer: A Multicenter Retrospective Study in Colombia | Fundación Santa Fe de Bogota | Observational | Recruiting | Stomach Neoplasms, Gastric Adenocarcinoma, Metastatic Gastric Cancer | 150 | Colombia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856212) |
| October 2, 2026 | NCT07855757 | Retlirafusp Alfa Plus SOX and Intraperitoneal Nab-Paclitaxel for Advanced Gastric/GEJ Cancer With Malignant Ascites | Zhejiang Cancer Hospital | Not applicable | Active not recruiting | Gastric Cancer (GC), Peritoneal Metastases From Gastric Cancer, Ascites, Malignant | 5 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855757) |
| October 2, 2026 | NCT07855640 | Anti-PD-1 in Combination With Systemic Chemotherapy With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With... | Zhejiang Cancer Hospital | Observational | Recruiting | Gastric Cancer Peritoneal Metastases, Gastric Cancer (GC), Ascites, Malignant | 50 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855640) |
| September 30, 2026 | NCT07850882 | A Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection Combined With Immune Checkpoint Inhibitors for... | Jie Yuan，MD | Observational | Recruiting | Colorectal Cancer (CRC), Gastric Cancer (GC), Hepatocellular Carcinoma (HCC) | 30 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850882) |
| September 25, 2026 | NCT07842549 | Multicenter Study of Clinical-Pathological Correlation in cT2N0 Gastric Cancer and Its Prognostic Implications | Hospital of Navarra | Observational | Completed | Gastric Cancer (Diagnosis), TNM Staging, Perioperative Treatment in Subjects With Locally Advanced Resectable Gastric... | 1,024 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07842549) |
| September 25, 2026 | NCT07840833 | Prevalence of Helicobacter Pylori Infection | Fu Jen Catholic University Hospital | Observational | Not yet recruiting | Residents of Palau Aged 18 Years or Older | 1,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07840833) |
| September 24, 2026 | NCT07839702 | Multimodal Prehabilitation in Gastric Cancer Patients | National University Hospital, Singapore | Not applicable | Recruiting | Gastric Cancer (GC), Prehabilitation, Postoperative Inflammation | 25 | Singapore | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839702) |
| September 22, 2026 | NCT07835087 | Image-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric Cancer | Beijing Friendship Hospital | Not applicable | Recruiting | Early Gastric Cancer, Gastric Adenocarcinoma | 36 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07835087) |
| September 21, 2026 | NCT07829757 | A Study of Zolbetuximab Given With mFOLFOX6 or CAPOX Chemotherapy in Indian Adults With Gastric Cancer | Astellas Pharma Global Development, Inc. | Phase 4 | Not yet recruiting | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable... | 50 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07829757) |
| September 18, 2026 | NCT07828899 | Safety and Efficacy Evaluation of Single-Port Versus Multi-Port Robotic-Assisted Radical Distal Gastrectomy for Gastric Cancer | First Affiliated Hospital of Wenzhou Medical University | Not applicable | Not yet recruiting | STOMACH NEOPLASM, Robotic Surgical Procedures | 212 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07828899) |
| September 17, 2026 | NCT07825870 | Outcomes of Fluoroscopy-Guided Transdiscal Splanchnic Nerve Neurolysis for Upper Abdominal Cancer Pain. | Sahiwal medical college sahiwal | Not applicable | Not yet recruiting | Upper Abdominal Cancer Pain, Pancreatic Cancer, Gastric Cancer, Hepatobiliary Cancer | 40 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07825870) |
| September 16, 2026 | NCT07822399 | A Study of MGC030 in Participants With Advanced Solid Tumors | MacroGenics | Phase 1 | Recruiting | Urothelial Cancer, GastroEsophageal Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer (GC), Pancreatic Cancer | 314 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822399) |
| September 16, 2026 | NCT07821775 | Robotic vs Laparoscopic and Open Surgery for Abdominopelvic Cancers | Asan Medical Center | Observational | Completed | Pancreatic Neoplasms, Stomach Neoplasms, Rectal Neoplasms, Uterine Cervical Neoplasms, Endometrial Neoplasms, Kidney... | 32,949 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07821775) |
| September 14, 2026 | NCT07819019 | A Phase II Study of Irinotecan Liposome Plus Fruquintinib and Sintilimab in Second-Line PD-L1-Positive Advanced Gastric Cancer | Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | Phase 2 | Not yet recruiting | Stomach Neoplasms, Gastric Cancer | 20 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07819019) |
| September 14, 2026 | NCT07818070 | A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric... | Ono Pharmaceutical Co., Ltd. | Phase 3 | Not yet recruiting | Gastric Cancer, Esophagogastric Junction Cancer, Esophageal Adenocarcinoma | 600 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07818070) |
| September 14, 2026 | NCT07818018 | A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma | Memorial Sloan Kettering Cancer Center | Phase 1/2 | Recruiting | Esophageal Cancer, Advanced Esophageal Cancer, Gastric Cancer, Advanced Gastric Cancer, Gastroesophageal Junction... | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07818018) |
| September 11, 2026 | NCT07816263 | Guaraná Supplementation for Cancer-Related Fatigue | Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo | Observational | Recruiting | Cancer-related Fatigue, Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Cervical Cancer, Quality of Life | 60 | Colombia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816263) |
| September 11, 2026 | NCT07814872 | A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment | Harvard Medical School (HMS and HSDM) | Observational | Not yet recruiting | Neoplasms (Cancer / Tumors), Colorectal Neoplasms, Lung Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Pancreatic... | 30,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07814872) |
| September 10, 2026 | NCT07814248 | A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a... | TwoStep Therapeutics, Inc. | Phase 1 | Recruiting | NSCLC (Non-small Cell Lung Cancer), HNSCC, Endometrial, Ovarian Cancer, Esophageal Cancer, Head & Neck Cancer, Gastric... | 74 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07814248) |
| September 10, 2026 | NCT07812805 | SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors | SK Life Science, Inc. | Phase 1 | Recruiting | Selected Advanced Solid Tumors, Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Biliary Tract Cancer... | 100 | South Korea, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07812805) |
| September 8, 2026 | NCT07808164 | ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort | Tam Anh Research Institute | Observational | Recruiting | HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer), Gastric Carcinoma, Breast Cancer, Lung Cancer, Endometrial... | 162 | Vietnam | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07808164) |
| September 8, 2026 | NCT07807956 | A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With... | AbbVie | Phase 1 | Recruiting | Advanced Solid Tumors, Non-Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Gastric Cancer... | 130 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07807956) |
| September 8, 2026 | NCT07807345 | Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic | Sutro Biopharma, Inc. | Phase 1 | Recruiting | Head & Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer, Esophageal Cancer, Gastric Cancer, Colorectal Cancer... | 285 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07807345) |
| September 8, 2026 | NCT07806500 | Phase Ib Study of Oral R01 Monotherapy in Advanced Solid Tumors | Beijing Anjianxi Bio-Medical Technology Co., Ltd. | Phase 1 | Not yet recruiting | Squamous Cell Lung Cancer, Gastric Cancer, Esophageal Cancer | 18 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07806500) |
| September 3, 2026 | NCT07803159 | Frailty, Immunonutrition, Surgery Type, and Biologic Recovery in Elderly Gastric Cancer | Kocaeli City Hospital | Observational | Not yet recruiting | Gastric Cancer, Gastric Adenocarcinoma | 328 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07803159) |
| September 3, 2026 | NCT07801508 | A Study of \[68Ga\]Ga-DWJ155 in Adult Patients With Solid Tumors | Novartis Pharmaceuticals | Phase 1 | Recruiting | Advanced Gastroesophageal Adenocarcinoma, Advanced Breast Cancer, Triple-negative Breast Cancer, Advanced Non-small... | 66 | Australia, Japan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801508) |
| September 3, 2026 | NCT07801027 | A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer... | Merck Sharp & Dohme LLC | Phase 4 | Not yet recruiting | Neoplasm Malignant, Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma, Biliary Tract Carcinoma, Uterine... | 150 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801027) |
| September 2, 2026 | NCT07800754 | A Study in Greece Observing How Patients With Stomach and Esophageal Cancer Are Diagnosed and Treated in Everyday Medical Practice | AstraZeneca | Observational | Recruiting | Gastric Cancer, Gastroesophageal Junction Cancer | 300 | Greece | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07800754) |
| August 31, 2026 | NCT07795749 | Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B) | University of California, Irvine | Phase 2 | Recruiting | Esophageal Carcinoma, Gastric Cancer (Diagnosis), Colorectal Adenocarcinoma, Appendiceal Adenocarcinoma, Small Bowel... | 55 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795749) |
| August 31, 2026 | NCT07795645 | Validating a Medical AI Fine-Tuning Platform for Major Diseases | Beijing Friendship Hospital | Observational | Recruiting | Chronic Gastritis, Gastric Cancer (GC), Coronary Artery Disease, Stroke, Gastro Esophageal Reflux | 96,000 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795645) |
| August 28, 2026 | NCT07791979 | High-Flow Nasal Cannula Oxygenation During Sedated Gastrointestinal Endoscopy in Patients With Chronic Obstructive Pulmonary Disease | Zhejiang University | Not applicable | Not yet recruiting | Hypoxemia, Gastric Cancer (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Esophageal Cancer | 90 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07791979) |
| August 27, 2026 | NCT07789184 | Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy | Hua Huang, MD, PhD | Phase 3 | Recruiting | Gastric Cancer, Peritoneal Metastasis | 170 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07789184) |
| August 26, 2026 | NCT07787052 | R-GASTIM- Study of Gastric Cancer Operable | Centre Leon Berard | Observational | Recruiting | Gastric Cancers | 60 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07787052) |
| August 24, 2026 | NCT07782294 | AI-Assisted Novel rbcDNA Detection for Early Gastric Cancer Diagnosis | Second Affiliated Hospital, Zhejiang University, School of Medicine | Observational | Not yet recruiting | Gastric Cancer | 542 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07782294) |
| August 24, 2026 | NCT07781852 | Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer | Lumina Pharmaceuticals Inc | Early phase 1 | Not yet recruiting | Bladder Cancer, Glioma, Glioblastoma (GBM), Breast Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer (GC)... | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07781852) |
| August 24, 2026 | NCT07781319 | Early Gastric Cancer in the Spanish EURECCA Registry | Corporacion Parc Tauli | Observational | Completed | Early Gastric Cancer, Gastric Adenocarcinoma | 600 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07781319) |
| August 24, 2026 | NCT07780968 | Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA | Jazz Pharmaceuticals | Observational | Not yet recruiting | Esophageal Cancer, GastroEsophageal Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer, Stomach... | 300 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780968) |
| August 20, 2026 | NCT07776067 | CT Imaging and Clinical Features to Predict Outcomes in Patients With Gastric Cancer | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Observational | Recruiting | Gastric Cancer | 600 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07776067) |
| August 20, 2026 | NCT07775859 | NOMAD-GI: Molecular-guided Non-operative Management and Organ Preservation Strategy After Precision Therapy in Gastrointestinal Cancers | Peking University Cancer Hospital & Institute | Observational | Not yet recruiting | Gastrointestinal Cancer, Gastric Cancer, Gastroesophageal Junction Cancer, Esophageal Cancer, Colorectal Cancer | 200 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775859) |
| August 19, 2026 | NCT07772453 | Ferric Carboxymaltose Versus Iron Sucrose for Iron Deficiency Anemia After Radical Gastrectomy for Gastric Cancer | Zhaojian Niu,MD | Phase 4 | Not yet recruiting | Gastric Cancer (GC), Iron Deficiency Anemia (IDA), Post-Operative Anemia, Radical Gastrectomy | 160 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07772453) |
| August 18, 2026 | NCT07770126 | The Prevalence and the Pathophysiological Role of Non-Helicobacter Pylori Helicobacter Spp. in Well-defined Gastric Diseases and (Pre-)... | Universiteit Antwerpen | Observational | Recruiting | Functional Dyspepsia, Gastritis, Gastritis Chronic, Gastric Cancer (GC), Atrophic Gastritis, Intestinal Metaplasia of... | 150 | Belgium | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07770126) |
| August 18, 2026 | NCT07770100 | Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV) | Mark Bernard | Phase 2 | Recruiting | Head and Neck Cancer, Non-Small Cell Lung Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer (GC) | 35 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07770100) |
| August 17, 2026 | NCT07768514 | Maxigesic for Postoperative Pain Control After Laparoscopic or Robotic Gastrectomy | Seoul National University Bundang Hospital | Phase 2 | Active not recruiting | Stomach Neoplasms | 90 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07768514) |
| August 14, 2026 | NCT07764523 | Home-based Whole Course Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile Health | The Affiliated Hospital of Qingdao University | Not applicable | Not yet recruiting | Gastric Cancer, Prehabilitation | 328 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07764523) |
| August 10, 2026 | NCT07755917 | Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile Health | The Affiliated Hospital of Qingdao University | Not applicable | Not yet recruiting | Gastric Cancer, Prehabilitation | 490 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07755917) |
| August 6, 2026 | NCT07749586 | A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors | Arvinas Inc. | Phase 1/2 | Recruiting | Advanced Solid Tumor | 499 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07749586) |
| August 6, 2026 | NCT07749326 | Malignant Gastric Outlet Obstruction Study With Stomach Partitioning (GO-PART) | Gyeongsang National University Hospital | Not applicable | Recruiting | Stomach Neoplasms, Gastric Outlet Obstruction | 144 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07749326) |
| August 5, 2026 | NCT07747688 | Retrospective Analysis of Early Gastric Cancer Patients Based on Prospective Clinical Dataset | Beijing Friendship Hospital | Observational | Recruiting | Early Gastric Cancer | 5,000 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07747688) |
| August 5, 2026 | NCT07746830 | Prospective Assessment of Alignment Between Multimodal Artificial Intelligence and Multidisciplinary Team Decisions in Gastrointestinal... | Shanghai Minimally Invasive Surgery Center | Observational | Not yet recruiting | Gastric Cancer, Colorectal Cancer, Gastrointestinal Cancer | 69 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07746830) |
| August 3, 2026 | NCT07741435 | Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia | Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo | Observational | Recruiting | Neoplasms, Solid Tumor, Breast Neoplasms, Lung Neoplasms, Stomach Neoplasms, Uterine Cervical Neoplasms, Colorectal... | 3,250 | Colombia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07741435) |
| July 31, 2026 | NCT07738939 | IKS04 Regimen in Advanced Solid Tumors That Express CA242 | Iksuda Therapeutics Ltd. | Phase 1 | Not yet recruiting | Colorectal Cancer, Gastro Esophageal Junctional Cancer, Gastric Cancer (GC), GEJ Adenocarcinoma, PDAC - Pancreatic... | 120 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07738939) |
| July 29, 2026 | NCT07732543 | Developing and Testing the Effectiveness of Smart Healthcare Assisted Individualized Symptom Management Education and Home-based Exercise... | Taipei Veterans General Hospital, Taiwan | Not applicable | Not yet recruiting | Gastric Cancer (GC), Immunotherapy | 110 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07732543) |
| July 24, 2026 | NCT07724496 | Helicobacter Pylori Infection Status and Pathological Features for Predicting Gastric Cancer Biological Behavior and Prognosis: A... | Chinese PLA General Hospital | Observational | Recruiting | Helicobacter Pylori, Early Gastric Cancer | 1,500 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07724496) |
| July 20, 2026 | NCT07715747 | A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors | TJ Biopharma Co., Ltd. | Phase 1 | Recruiting | Solid Tumor, Metastatic Ovary Cancer, Metastatic Gastric Cancer, Metastatic Endometrial Carcinoma | 128 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07715747) |
| July 20, 2026 | NCT07714980 | TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial) | The Affiliated Hospital of Qingdao University | Not applicable | Recruiting | Gastric Cancer (GC), Stomach Neoplasms | 300 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07714980) |
| July 20, 2026 | NCT07714538 | Breath Research Narrow Validation for Gastrointestinal Cancer Detection | Imperial College London | Observational | Recruiting | Oesophageal Squamous Cell Carcinoma, Oesophageal Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic Ductal... | 1,000 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07714538) |
| July 17, 2026 | NCT07709767 | Conversion Therapy With Retlirafusp Alfa Plus Chemotherapy in Gastric or Gastroesophageal Junction Adenocarcinoma | Tang-Du Hospital | Phase 2 | Not yet recruiting | Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | 21 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07709767) |
| July 16, 2026 | NCT07708012 | Clinical Study on Using Laparoscopic Sentinel Lymph Node Navigation Combined With Dual Endoscopy Surgery for Early Gastric Cancer | wangdongsheng | Not applicable | Recruiting | Early-stage Upper Gastrointestinal Cancer, Stomach Cancer, Adenocarcinoma, Laparoscopy-assisted Surgery, Endoscope | 9 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07708012) |
| July 16, 2026 | NCT07707531 | A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and... | Huashan Hospital | Early phase 1 | Recruiting | Gastric Cancer, Pancreatic Cancer | 10 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07707531) |
| July 15, 2026 | NCT07705334 | A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors | SHY Therapeutics | Phase 1 | Recruiting | Advanced or Metastatic Solid Tumors, Triple Negative Breast Cancer (TNBC), HR+ Breast Cancer, Colon Cancer, Gastric... | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07705334) |
| July 15, 2026 | NCT07705074 | FAPI PET Imaging - An Exploratory Study | Martin Huellner | Phase 1/2 | Not yet recruiting | Thyroid Pathology, Head and Neck Cancer (H&N), Sinonasal Tract Tumor, Sarcoidosis, Thyroid Cancer, Breast Cancer... | 770 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07705074) |
| July 14, 2026 | NCT07702292 | \[68Ga\]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications | Blue Earth Diagnostics | Phase 2 | Recruiting | Colorectal Cancer, Epithelial Ovarian Cancer, Gastric Cancer (GC), Pancreatic Ductal Adenocarcinoma (PDAC), Invasive... | 71 | Italy, Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07702292) |
| July 14, 2026 | NCT07700979 | Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of... | Akeso | Phase 3 | Recruiting | Gastric / Gastroesophageal Junction Adenocarcinoma | 900 | China, Germany, Poland, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07700979) |
| July 10, 2026 | NCT07697079 | Combination of CT and Ultrasound Radiomics Combined With Liquid Biopsy to Predict Neoadjuvant Chemotherapy Response in Patients With... | Liu Yang | Observational | Not yet recruiting | Gastric Cancer | 300 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697079) |
| July 9, 2026 | NCT07692334 | Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma | West China Second University Hospital | Phase 2 | Not yet recruiting | Gastric Cancer, Gastroesophageal Junction (GEJ) Adenocarcinoma, Becotatug Vedotin, Pucotenlimab | 28 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07692334) |
| July 9, 2026 | NCT07692204 | A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer | Sanofi | Phase 2 | Recruiting | Gastric Cancer, Oesophageal Carcinoma | 30 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07692204) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Fudan University | 17 | October 14, 2026 |
| The First Affiliated Hospital with Nanjing Medical University | 14 | November 3, 2026 |
| Zhejiang University | 9 | August 28, 2026 |
| Nanfang Hospital, Southern Medical University | 8 | June 3, 2026 |
| Ruijin Hospital | 7 | November 6, 2026 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 7 | November 5, 2026 |
| The Affiliated Hospital of Qingdao University | 7 | October 27, 2026 |
| AstraZeneca | 7 | October 20, 2026 |
| Beijing Friendship Hospital | 7 | September 22, 2026 |
| Qilu Hospital of Shandong University | 7 | June 9, 2026 |
| Jichao Qin | 6 | August 24, 2025 |
| Samsung Medical Center | 5 | November 2, 2026 |
| Chinese University of Hong Kong | 5 | April 24, 2026 |
| Fujian Medical University | 5 | January 21, 2026 |
| Fujian Cancer Hospital | 4 | October 29, 2026 |
| Peking University Cancer Hospital & Institute | 4 | August 20, 2026 |
| Yonsei University | 4 | July 7, 2026 |
| Changhai Hospital | 4 | April 2, 2026 |
| Qun Zhao | 4 | February 10, 2026 |
| Gangnam Severance Hospital | 4 | February 24, 2025 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 166 | November 9, 2026 |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 108 | November 6, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 89 | November 5, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 48 | November 6, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 43 | October 27, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 21 | September 14, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 12 | September 21, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 9 | August 24, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 9 | May 22, 2026 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 250 | November 9, 2026 |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 77 | October 29, 2026 |
| [South Korea](https://specstream.ai/data/clinical-trials/country/south-korea) | 37 | November 2, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 20 | September 25, 2026 |
| [Japan](https://specstream.ai/data/clinical-trials/country/japan) | 19 | October 14, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 18 | July 14, 2026 |
| [Australia](https://specstream.ai/data/clinical-trials/country/australia) | 17 | September 3, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 15 | July 14, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 14 | October 20, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 12 | September 3, 2026 |
| [Canada](https://specstream.ai/data/clinical-trials/country/canada) | 11 | October 5, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 11 | July 20, 2026 |
| [Netherlands](https://specstream.ai/data/clinical-trials/country/netherlands) | 9 | July 14, 2026 |
| [Taiwan](https://specstream.ai/data/clinical-trials/country/taiwan) | 8 | April 20, 2026 |
| [Colombia](https://specstream.ai/data/clinical-trials/country/colombia) | 6 | October 5, 2026 |
| [Russia](https://specstream.ai/data/clinical-trials/country/russia) | 6 | April 21, 2026 |
| [Vietnam](https://specstream.ai/data/clinical-trials/country/vietnam) | 5 | November 6, 2026 |
| [Portugal](https://specstream.ai/data/clinical-trials/country/portugal) | 5 | November 5, 2026 |
| [Belgium](https://specstream.ai/data/clinical-trials/country/belgium) | 5 | August 18, 2026 |
| [Poland](https://specstream.ai/data/clinical-trials/country/poland) | 5 | July 14, 2026 |
| [Hong Kong](https://specstream.ai/data/clinical-trials/country/hong-kong) | 5 | April 24, 2026 |
| [Brazil](https://specstream.ai/data/clinical-trials/country/brazil) | 5 | February 24, 2026 |
| [Sweden](https://specstream.ai/data/clinical-trials/country/sweden) | 4 | June 11, 2026 |
| [Romania](https://specstream.ai/data/clinical-trials/country/romania) | 3 | October 19, 2026 |
| [Singapore](https://specstream.ai/data/clinical-trials/country/singapore) | 3 | September 24, 2026 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).